-
1دورية أكاديمية
المؤلفون: Abu-Elyazeed, R R, Heineman, T, Dubin, G, Fourneau, M, Leroux-Roels, I, Leroux-Roels, G, Richardus, J H, Ostergaard, L, Diez-Domingo, J, Poder, A, Van Damme, P, Romanowski, B, Blatter, M, Silfverdal, S A, Berglund, J, Josefsson, A, Cunningham, A L, Flodmark, C E, Tragiannidis, A, Dobson, S, Olafsson, J, Puig-Barbera, J, Mendez, M, Barton, S, Bernstein, D, Mares, J, Ratner, P
المساهمون: Gaglani, M, Klein, N, Combs, S P, Fox, B, Frey, S, Fiel, T, Rupp, R, Sperling, M, Hazan, L, Kelsey, A, Kempers, S, Nachman, S, O'Hern, R, Nolan, T, Konstantopoulos, A, Zilmer, K, Zickler, P, Boye, A, Mercier, P, Kemeny, L, Jančorienė, Ligita, Bumbulienė, Žana, Levinienė, Giedra, Bagshaw, S, Thune, T, Addlestone, R, Bodalia, B, Lal-Sarin, R
المصدر: Vaccine, Oxford : Elsevier Ltd, 2013, vol. 31, no. 51, p. 6136-6143 ; ISSN 0264-410X ; eISSN 1873-2518
مصطلحات موضوعية: (S)AE, (serious) adverse event, 95% CI, 95% confidence interval, AS04, ATP, Alum, ELISA, ELISA units, EU, GMC, GSK, Genital herpes, GlaxoSmithKline, HAV, HSV, HSV vaccine, HSV-1, HSV-2, Herpes simplex virus type 1, Herpes simplex virus type 2, IU, IgG, MPL, NOCD, OD, Safety, TVC, according to protocol, aluminium hydroxide
-
2دورية أكاديمية
المؤلفون: Abu-Elyazeed, R R, Heineman, T, Dubin, G, Fourneau, M, Leroux-Roels, I, Leroux-Roels, G, Richardus, J H, Ostergaard, L, Diez-Domingo, J, Poder, A, Van Damme, P, Romanowski, B, Blatter, M, Silfverdal, S A, Berglund, J, Josefsson, A, Cunningham, A L, Flodmark, C E, Tragiannidis, A, Dobson, S, Olafsson, J, Puig-Barbera, J, Mendez, M, Barton, S, Bernstein, D, Mares, J, Ratner, P
المساهمون: Gaglani, M, Klein, N, Combs, S P, Fox, B, Frey, S, Fiel, T, Rupp, R, Sperling, M, Hazan, L, Kelsey, A, Kempers, S, Nachman, S, O'Hern, R, Nolan, T, Konstantopoulos, A, Zilmer, K, Zickler, P, Boye, A, Mercier, P, Kemeny, L, Jančorienė, Ligita, Bumbulienė, Žana, Levinienė, Giedra, Bagshaw, S, Thune, T, Addlestone, R, Bodalia, B, Lal-Sarin, R
المصدر: Vaccine, Oxford : Elsevier Ltd, 2013, vol. 31, no. 51, p. 6136-6143 ; ISSN 0264-410X ; eISSN 1873-2518
مصطلحات موضوعية: (S)AE, (serious) adverse event, 95% CI, 95% confidence interval, AS04, ATP, Alum, ELISA, ELISA units, EU, GMC, GSK, Genital herpes, GlaxoSmithKline, HAV, HSV, HSV vaccine, HSV-1, HSV-2, Herpes simplex virus type 1, Herpes simplex virus type 2, IU, IgG, MPL, NOCD, OD, Safety, TVC, according to protocol, aluminium hydroxide
